Nuclear Medicine & Radiopharmaceut icals Market
Nuclear Medicine & Radiopharmaceuticals Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nuclear Medicine & Radiopharmaceuticals Market Size and Growth
The global Nuclear Medicine & Radiopharmaceuticals market is experiencing robust growth due to increasing prevalence of chronic diseases and advancements in medical imaging technology. The market size is estimated to be valued at $8.9 billion in 2021, with a projected CAGR of 4.5% from 2021 to 2026.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ China Isotope & Radiation
◍ Dongcheng
◍ Jaco
◍ Ciaeriar
◍ Advanced Molecular-imaging Solution
◍ Shanghai Atom Kexing
The competitive landscape of the Nuclear Medicine & Radiopharmaceuticals Market includes China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution, and Shanghai Atom Kexing. These companies provide innovative solutions in nuclear medicine and radiopharmaceuticals, contributing to the growth of the market. Actual sales revenue figures: China Isotope & Radiation - $500 million, Shanghai Atom Kexing - $300 million.
Request Sample Report
Market Segmentation
By Application
Oncology
Thyroid
Cardiology
Others
Request Sample Report
By Product
Diagnostic
Therapeutic
Market Growth
Request Sample Report
$ X Billion USD
